ROHTO PHARMACEUTICAL CO.,LTD. · ロート製薬株式会社
Ownership & governance
Executives 5Directors 10Avg age 60Avg tenure 6.3y
KY
Kunio Yamada
Chief Executive Officer
Age 70Since 2019-05-31
+14
Executives5
KY
Kunio Yamada
Chief Executive Officer
Age 70Since 2019-05-31
HS
Hidetoshi Segi
President
Age 64Since 2025-06-25
MS
Masaya Saito
Director of Finance/CFO
Age 62Since 2022-02-28
YF
Yoko Fujimoto
Chief Tech/Sci/R&D Officer
Age 60Since 2025-05-31
NS
Noriko Suenobu
Chief Tech/Sci/R&D Officer
Age 59Since 2025-06-25
Board of directors10
KY
Kunio Yamada
Chairman
Age 70Since 2009-05-31
SK
Shinichi Kunisaki
Director/Board Member
Age 70Since 2010-05-31
MS
Masaya Saito
Director/Board Member
Age 62Since 2011-05-31
HS
Hidetoshi Segi
Director/Board Member
Age 64Since 2018-05-31
HM
Haruka Mera
Director/Board Member
Age 38Since 2020-06-25
AI
Akie Iriyama
Director/Board Member
Age 53Since 2019-05-31
EH
Eriko Hayashi
Director/Board Member
Age 49Since 2022-05-31
YK
Yasunori Kawasaki
Director/Board Member
Age 66Since 2023-05-31
Shareholders5
| Name | Stake | Shares |
|---|---|---|
| ROHTO PHARMACEUTICAL CO.,LTD. | 4.325 % | 10,214,018 |
| MITSUBISHI UFJ FINANCIAL GROUP, INC. | 4.263 % | 10,069,000 |
| Yamada Family | 3.563 % | 8,415,000 |
| Sansho Kosan KK | 2.137 % | 5,046,000 |
| Nippon Life Insurance Co. | 1.794 % | 4,238,000 |
Catalog · 2026-07-09
Registry officers19
| Name | Role | Since | Shares |
|---|---|---|---|
| 斉 藤 雅 也 | 取締役副社長チーフファイナンシャルオフィサー(CFO) | 1998-05-01 | - |
| 上 村 秀 人 | 常勤監査役 | 2010-05-01 | - |
| 入 山 章 栄 | 取締役 | 2019-06-01 | - |
| 國 﨑 伸 一 | 取締役副社長チーフテクニカルオフィサー(CTO) | 2007-01-01 | - |
| 寺 田 明 日 香 | 監査役 | 2025-06-01 | - |
| 山 中 雅 恵 | 取締役チーフトランスフォーメーションオフィサー(CXO) | 2017-07-01 | - |
| 山 田 邦 雄 | 代表取締役会長 | 1991-06-01 | - |
| 岩 田 彰 一 郎 | 取締役 | 1997-03-01 | - |
Registry · as of 2026-03-31
Institutional (13F)
Loading Form 13F holders…
Fund membership
Loading fund baskets…
Street consensus
Consensus buyMean target 3,290Range 2,600–3,840Analysts 11
2,600Mean 3,2903,840
- Strong buy 4
- Buy 4
- Hold 3
Firm rows and rating mix from Yahoo Finance; mean target is Yahoo’s aggregate until OpenFilings derives consensus from broker rows.